Cyrus Harmon
Fortuna: 7 M $ al 30/09/2026
Fortuna: 7 M $ al 30/09/2026
Dr. Cyrus L.
Harmon is a President & Chief Executive Officer at Vilya, Inc. and an Independent Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc. Dr. Harmon was previously employed as a General Manager by Affymetrix, Inc. and a Chief Executive Officer by Neomorphics, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/07/2026 | 819.798 ( 0,94 % ) | 7 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Fundador | 07/08/2006 |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Director Ejecutivo | 01/10/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2002 |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Director Ejecutivo | 01/01/2000 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.